UAE grants emergency use authorization for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) has…
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa…
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford…
Thermo Fisher Scientific acquires Henogen from Novasep for €725m to expand viral vector manufacturing capabilities
Thermo Fisher Scientific has completed the acquisition of Henogen, a viral vector manufacturing business previously owned by Groupe…
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine
Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with…
Janssen Pharmaceutical’s DARZALEX FASPRO gains FDA approval for AL amyloidosis treatment
Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured FDA approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj),…
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine,…
Sanofi signs $1.45bn deal to acquire Kymab, expanding its immune-therapy pipeline
In a significant move to bolster its immuno-oncology and immune-mediated disease portfolio, Sanofi has acquired Kymab, a UK-based…
OncoSec Medical begins phase 2 trial for TAVO and OPDIVO combination in melanoma treatment
OncoSec Medical, a US-based biotechnology company, has officially dosed the first patient in its phase 2 clinical trial,…
India grants emergency approval to Covishield and Covaxin vaccines for Covid-19
In a significant development in the battle against Covid-19, the Drugs Controller General of India (DCGI) has granted…